onr:"swepub:oai:prod.swepub.kib.ki.se:140598158"
Search: onr:"swepub:oai:prod.swepub.kib.ki.se:140598158" > Therapeutic Targeti...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Van Avondt, K (author)
Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation
- Article/chapterEnglish2019
Publisher, publication year, extent ...
- 2019-02-07
- Georg Thieme Verlag KG,2019
Numbers
- LIBRIS-ID:oai:prod.swepub.kib.ki.se:140598158
- http://kipublications.ki.se/Default.aspx?queryparsed=id:140598158URI
- https://doi.org/10.1055/s-0039-1678664DOI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- Neutrophils and neutrophil extracellular traps (NETs) have a robust relationship with atherothrombotic disease risk, which led to the idea that interfering with the release of NETs therapeutically would ameliorate atherosclerosis. In human studies, acute coronary events and the pro-thrombotic state cause markedly elevated levels of circulating deoxyribonucleic acid (DNA) and chromatin, suggesting that DNase I might produce cardiovascular benefit. DNase I reproduced the phenotype of peptidylarginine deiminase 4 (PAD4) deficiency and showed a significant benefit for atherothrombotic disease in experimental mouse models. However, the mechanisms of benefit remain unclear. Insights into the mechanisms underlying NET release and atherogenic inflammation have come from transgenic mouse studies. In particular, the importance of neutrophil NET formation in promoting atherothrombotic disease has been shown and linked to profound pro-inflammatory and pro-thrombotic effects, complement activation and endothelial dysfunction. Recent studies have shown that myeloid deficiency of PAD4 leads to diminished NET formation, which in turn protects against atherosclerosis burden, propagation of its thrombotic complications and notably macrophage inflammation in plaques. In addition, oxidative stress and neutrophil cholesterol accumulation have emerged as important factors driving NET release, likely involving mitochondrial reactive oxidants and neutrophil inflammasome activation. Further elucidation of the mechanisms linking hyperlipidaemia to the release of NETs may lead to the development of new therapeutics specifically targeting atherogenic inflammation, with likely benefit for cardiovascular diseases.
Added entries (persons, corporate bodies, meetings, titles ...)
- Maegdefessel, LKarolinska Institutet (author)
- Soehnlein, OKarolinska Institutet (author)
- Karolinska Institutet (creator_code:org_t)
Related titles
- In:Thrombosis and haemostasis: Georg Thieme Verlag KG119:4, s. 542-5522567-689X0340-6245
Internet link
Find in a library
- Thrombosis and haemostasis (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Van Avondt, K
- Maegdefessel, L
- Soehnlein, O
- Articles in the publication
- Thrombosis and h ...
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
